Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.10
0.00 (-0.08%)
Aug 10, 2026, 11:28 AM EDT - Market open
Wave Life Sciences Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Wave Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $19.38. The average 1-year stock price forecast is 217.97% higher than the current stock price, while the lowest is $12 (+96.88%) and the highest is $42 (+589.09%).
Price Target: $19.38 (+217.97%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 14 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $27 → $23 | Buy | Maintains | $27 → $23 | +277.36% | Aug 3, 2026 |
| Clear Street | Clear Street | Buy Maintains $36 → $26 | Buy | Maintains | $36 → $26 | +326.58% | Aug 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $13 | Buy | Maintains | $13 | +113.29% | Jul 31, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $15 | Buy | Maintains | $15 | +146.10% | Jul 31, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $31 → $22 | Buy | Reiterates | $31 → $22 | +260.95% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
55.28M
from 42.73M
Increased by 29.39%
Revenue Next Year
39.57M
from 55.28M
Decreased by -28.43%
EPS This Year
-1.11
from -1.21
EPS Next Year
-1.19
from -1.11
EPS and Forward PE are based on non-GAAP adjusted numbers.